• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

锝-99m-奥曲肽对神经内分泌肿瘤的诊断准确性:阿曼医院经验及文献综述

Diagnostic accuracy of technetium-99m-octreotide in imaging neuroendocrine tumors, Oman hospital experience with literature review.

作者信息

Al Bulushi Naima, Al Suqri Badriya, Al Aamri Marwa, Al Hadidi Aymen, Al Jahdami Hafidh, Al Zadjali Mohammed, Al Risi Mimouna

机构信息

Department of Nuclear Medicine and Molecular Imaging Center, Royal Hospital, Muscat, Oman.

Department of Radiology, Al Nahda Hospital, Muscat, Oman.

出版信息

World J Nucl Med. 2019 Apr-Jun;18(2):137-142. doi: 10.4103/wjnm.WJNM_36_18.

DOI:10.4103/wjnm.WJNM_36_18
PMID:31040744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6476243/
Abstract

The aim of this observational cross-sectional study with retrospective review of the data is to evaluate the efficacy of using technetium-99m-octreotide (Tc-99m-OCT) in imaging neuroendocrine tumors (NETs) in our tertiary care hospital. A total of 58 patients had Tc-99m-OCT were identified in our database, from January 2013 to December 2016. Forty-one patients (age range of 15-75 years) meet our inclusion criteria, namely histopathology proven NETs, Tc-99m-OCT scan, computed tomography (CT), or magnetic resonance imaging (MRI) done in our institute for correlation. Twenty-three patients had true positive Tc-99m-OCT scan. In addition to the primary tumors, the octreotide scan revealed metastasis in the lung, liver, and retroperitoneal lymph nodes. The smallest lesion detected on octreotide scan was a 4-mm pulmonary nodule that was missed on lung window CT scan. The Tc-99m-OCT had 17 true negative, one false negative, and no false positive. The CT and MRI scans had 18 true positive, 17 true negative, 5 false negative, and one false positive. The overall sensitivity, specificity, accuracy, positive, and negative predictive values of Tc-99m-OCT scan were 96%, 100%, 97%, 100%, and 94%, respectively. Whereas those of CT and MRI were 78%, 94%, 85%, 94%, and 77%, respectively. Our diagnostic accuracy of Tc-99m-OCT is high. We recommend that, in addition to the conventional radiological investigations, Tc-99m-OCT scan, or other somatostatin receptor imaging (SSR) is a mandate for better and accurate staging of patients with NETs.

摘要

这项带有数据回顾性分析的观察性横断面研究旨在评估在我们的三级护理医院中使用锝-99m-奥曲肽(Tc-99m-OCT)对神经内分泌肿瘤(NETs)进行成像的疗效。在我们的数据库中,共识别出58例接受过Tc-99m-OCT检查的患者,时间跨度为2013年1月至2016年12月。41例患者(年龄范围为15至75岁)符合我们的纳入标准,即经组织病理学证实为NETs,且在我们研究所进行了Tc-99m-OCT扫描、计算机断层扫描(CT)或磁共振成像(MRI)以作对照。23例患者的Tc-99m-OCT扫描结果为真阳性。除了原发性肿瘤外,奥曲肽扫描还显示在肺、肝和腹膜后淋巴结有转移。奥曲肽扫描检测到的最小病变是一个4毫米的肺结节,在肺窗CT扫描中被漏诊。Tc-99m-OCT有17例假阴性、1例假阳性,无假阳性。CT和MRI扫描有18例假阳性、17例假阴性、5例假阴性和1例假阳性。Tc-99m-OCT扫描的总体敏感性、特异性、准确性、阳性预测值和阴性预测值分别为96%、100%、97%、100%和94%。而CT和MRI的相应数值分别为78%、94%、85%、94%和77%。我们的Tc-99m-OCT诊断准确性很高。我们建议,除了传统的放射学检查外,Tc-99m-OCT扫描或其他生长抑素受体成像(SSR)对于更好、更准确地对NETs患者进行分期是必要的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5174/6476243/091daa7fdf1a/WJNM-18-137-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5174/6476243/92a6db2ca9eb/WJNM-18-137-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5174/6476243/091daa7fdf1a/WJNM-18-137-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5174/6476243/92a6db2ca9eb/WJNM-18-137-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5174/6476243/091daa7fdf1a/WJNM-18-137-g002.jpg

相似文献

1
Diagnostic accuracy of technetium-99m-octreotide in imaging neuroendocrine tumors, Oman hospital experience with literature review.锝-99m-奥曲肽对神经内分泌肿瘤的诊断准确性:阿曼医院经验及文献综述
World J Nucl Med. 2019 Apr-Jun;18(2):137-142. doi: 10.4103/wjnm.WJNM_36_18.
2
An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors.99mTc-EDDA/HYNIC-TOC与111In-DTPA-奥曲肽用于诊断生长抑素受体表达肿瘤的患者内比较
J Nucl Med. 2003 May;44(5):708-16.
3
Diagnostic fficiency of Ga-DOTATATE PET/CT as ompared to Tc-Octreotide SPECT/CT andonventional orphologic odalities in euroendocrine umors.与锝-奥曲肽单光子发射计算机断层显像/计算机断层扫描(Tc-Octreotide SPECT/CT)及传统形态学检查方法相比,镓-多柔比星(Ga-DOTATATE)正电子发射断层显像/计算机断层扫描(PET/CT)在神经内分泌肿瘤中的诊断效能
Asia Ocean J Nucl Med Biol. 2019 Spring;7(2):129-140. doi: 10.22038/AOJNMB.2019.39392.1263.
4
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
5
Tc-Hynic-TOC imaging in the diagnostic of neuroendocrine tumors.锝[99mTc]标记的依克昔泮-奥曲肽显像在神经内分泌肿瘤诊断中的应用
World J Nucl Med. 2018 Jul-Sep;17(3):151-156. doi: 10.4103/wjnm.WJNM_41_17.
6
Efficacy of Tc-99m depreotide scintigraphy in the evaluation of solitary pulmonary nodules.锝-99m 地普肽闪烁扫描术在孤立性肺结节评估中的效能
Cancer J. 2002 Sep-Oct;8(5):400-4. doi: 10.1097/00130404-200209000-00011.
7
68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT.68Ga-DOTA-酪氨酰3-奥曲肽PET在神经内分泌肿瘤中的应用:与生长抑素受体闪烁扫描及CT的比较
J Nucl Med. 2007 Apr;48(4):508-18. doi: 10.2967/jnumed.106.035667.
8
The diagnostic role of 99mTc-dual receptor targeted probe and targeted peptide bombesin (RGD-BBN) SPET/CT in the detection of malignant and benign breast tumors and axillary lymph nodes compared to ultrasound.与超声相比,99mTc双受体靶向探针和靶向肽胃泌素释放肽(RGD-BBN)单光子发射计算机断层显像/计算机断层扫描(SPET/CT)在乳腺良恶性肿瘤及腋窝淋巴结检测中的诊断作用
Hell J Nucl Med. 2015 May-Aug;18(2):108-13. doi: 10.1967/s002449910204. Epub 2015 Jul 20.
9
Clinical validation and diagnostic accuracy of Tc-EDDA/HYNIC-TOC compared to In-DTPA-octreotide in patients with neuroendocrine tumours: the LACOG 0214 study.与铟-二巯基丁二酸-奥曲肽相比,锝-乙二胺二乙酸/羟基异腈-TOC在神经内分泌肿瘤患者中的临床验证及诊断准确性:LACOG 0214研究
Ecancermedicalscience. 2023 Jul 26;17:1582. doi: 10.3332/ecancer.2023.1582. eCollection 2023.
10
Comparison of 18F-FDG PET/CT scan and 99mTc-MDP bone scintigraphy in detecting bone metastasis in head and neck tumors.18F-FDG PET/CT扫描与99mTc-MDP骨闪烁显像在检测头颈部肿瘤骨转移中的比较
Nucl Med Commun. 2016 Jun;37(6):583-8. doi: 10.1097/MNM.0000000000000479.

引用本文的文献

1
Trends in diagnostic nuclear medicine in Sweden (2008-2023): utilisation, radiation dose, and methodological insights.瑞典诊断核医学的趋势(2008 - 2023年):使用情况、辐射剂量及方法学见解
EJNMMI Phys. 2025 Apr 2;12(1):32. doi: 10.1186/s40658-025-00747-2.
2
Potential Role of Somatostatin Receptor Scintigraphy for Imaging of Vulnerable Atherosclerotic Plaques and Its Association with Myocardial Perfusion Imaging Finding: A Preliminary Study.生长抑素受体闪烁扫描术在易损动脉粥样硬化斑块成像中的潜在作用及其与心肌灌注成像结果的关联:一项初步研究。
Mol Imaging Radionucl Ther. 2023 Jun 20;32(2):123-130. doi: 10.4274/mirt.galenos.2022.08860.
3

本文引用的文献

1
PET/CT imaging of neuroendocrine tumors with (68)Gallium-labeled somatostatin analogues: An overview and single institutional experience from India.用(68)镓标记的生长抑素类似物对神经内分泌肿瘤进行PET/CT成像:印度的综述及单机构经验
Indian J Nucl Med. 2014 Jan;29(1):2-12. doi: 10.4103/0972-3919.125760.
2
18F-fluorodihydroxyphenylalanine PET/CT in patients with neuroendocrine tumors of unknown origin: relation to tumor origin and differentiation.18F-氟代二羟苯丙氨酸 PET/CT 对不明来源神经内分泌肿瘤患者的应用:与肿瘤起源和分化的关系。
J Nucl Med. 2014 Mar;55(3):367-72. doi: 10.2967/jnumed.113.126896. Epub 2013 Dec 16.
3
Management of incidentally discovered appendiceal neuroendocrine tumors after an appendicectomy.
阑尾切除术后偶然发现的阑尾神经内分泌肿瘤的处理。
World J Gastroenterol. 2022 Apr 7;28(13):1304-1314. doi: 10.3748/wjg.v28.i13.1304.
4
Somatostatin receptor molecular imaging in a misdiagnosed gastrinoma case.生长抑素受体分子成像在一例胃泌素瘤误诊病例中的应用
World J Nucl Med. 2020 Aug 22;19(4):417-420. doi: 10.4103/wjnm.WJNM_16_20. eCollection 2020 Oct-Dec.
5
Somatostatin receptor scintigraphy in the follow up of neuroendocrine neoplasms of appendix.生长抑素受体闪烁扫描术在阑尾神经内分泌肿瘤随访中的应用
World J Clin Cases. 2020 Sep 6;8(17):3697-3707. doi: 10.12998/wjcc.v8.i17.3697.
Clinical applications of Gallium-68.
镓-68的临床应用
Appl Radiat Isot. 2013 Jun;76:2-13. doi: 10.1016/j.apradiso.2013.01.039. Epub 2013 Feb 20.
4
Gallium-68-DOTA-NOC PET/CT of patients with gastroenteropancreatic neuroendocrine tumors: a prospective single-center study.镓-68-DOTA-NOC PET/CT 用于胃肠胰神经内分泌肿瘤患者:一项前瞻性单中心研究。
AJR Am J Roentgenol. 2011 Nov;197(5):1221-8. doi: 10.2214/AJR.11.7298.
5
Patient-specific radiation dosimetry of 99mTc-HYNIC-Tyr3-octreotide in neuroendocrine tumors.99mTc-HYNIC-Tyr3-octreotide 用于神经内分泌肿瘤的患者特异性辐射剂量测定。
J Nucl Med. 2011 Sep;52(9):1474-81. doi: 10.2967/jnumed.111.088203. Epub 2011 Jul 27.
6
Current knowledge on diagnosis and staging of neuroendocrine tumors.目前对神经内分泌肿瘤的诊断和分期的认识。
Cancer Metastasis Rev. 2011 Mar;30 Suppl 1:3-7. doi: 10.1007/s10555-011-9292-1.
7
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: peptide receptor radionuclide therapy with radiolabeled somatostatin analogs.神经内分泌肿瘤护理标准的ENETS共识指南:放射性标记生长抑素类似物的肽受体放射性核素治疗
Neuroendocrinology. 2009;90(2):220-6. doi: 10.1159/000225951. Epub 2009 Aug 28.
8
Neuroendocrine tumors of the gastrointestinal tract: a decade of experience at the Princess Margaret Hospital.胃肠道神经内分泌肿瘤:玛格丽特公主医院十年经验
Am J Clin Oncol. 2008 Feb;31(1):64-70. doi: 10.1097/COC.0b013e31807a2f49.
9
Gallium-68 PET: a new frontier in receptor cancer imaging.镓-68正电子发射断层显像:受体癌症成像的新前沿
Anticancer Res. 2007 Nov-Dec;27(6B):4087-94.
10
Pasireotide (SOM230): development, mechanism of action and potential applications.帕西瑞肽(SOM230):研发、作用机制及潜在应用
Mol Cell Endocrinol. 2008 May 14;286(1-2):69-74. doi: 10.1016/j.mce.2007.09.006. Epub 2007 Sep 19.